Singapore markets closed

Organogenesis Holdings Inc. (ORGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.4300+0.1700 (+5.21%)
At close: 04:00PM EDT
3.6000 +0.17 (+4.96%)
Pre-market: 08:00AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 425.39M
Enterprise value 441.24M
Trailing P/E 6.02
Forward P/E 12.03
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.94
Price/book (mrq)1.67
Enterprise value/revenue 0.96
Enterprise value/EBITDA 6.78

Trading information

Stock price history

Beta (5Y monthly) 1.74
52-week change 3-73.72%
S&P500 52-week change 3-13.12%
52-week high 313.6050
52-week low 33.0800
50-day moving average 34.2344
200-day moving average 36.2625

Share statistics

Avg vol (3-month) 31.13M
Avg vol (10-day) 3691.72k
Shares outstanding 5130.89M
Implied shares outstanding 6N/A
Float 865.21M
% held by insiders 150.59%
% held by institutions 145.62%
Shares short (14 Sept 2022) 46.96M
Short ratio (14 Sept 2022) 45.91
Short % of float (14 Sept 2022) 420.31%
Short % of shares outstanding (14 Sept 2022) 45.31%
Shares short (prior month 14 Aug 2022) 46.2M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin 15.65%
Operating margin (ttm)11.98%

Management effectiveness

Return on assets (ttm)8.50%
Return on equity (ttm)33.28%

Income statement

Revenue (ttm)460.83M
Revenue per share (ttm)3.58
Quarterly revenue growth (yoy)-1.50%
Gross profit (ttm)353.86M
Net income avi to common (ttm)72.1M
Diluted EPS (ttm)0.5400
Quarterly earnings growth (yoy)-57.70%

Balance sheet

Total cash (mrq)113.24M
Total cash per share (mrq)0.87
Total debt (mrq)131.61M
Total debt/equity (mrq)51.74
Current ratio (mrq)2.62
Book value per share (mrq)1.94

Cash flow statement

Operating cash flow (ttm)57.4M
Levered free cash flow (ttm)30.56M